The Pharma Data

JANUARY 31, 2021

” Ryan Spencer Chief Executive Officer of Dynavax, commented, “We are excited to be rapidly progressing to an efficacy trial to support filing for emergency use and approval. Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate.

Vaccination 52

Vaccination Vaccine Trials Protein 52

pharmaphorum

MAY 17, 2021

Apellis Pharma has secured FDA approval for its complement C3 inhibitor Empaveli as a treatment for paroxysmal nocturnal hemoglobinuria (PNH) – with a label that will allow it to challenge Alexion’s established therapies directly. .

Drugs 52

Drugs FDA Approval Marketing Clinical Trials 52

XTalks

JUNE 9, 2021

Not only is aducanumab the first new treatment approved for Alzheimer’s since 2003, it is also the first therapy that targets the pathophysiology of the disease. Aducanumab Controversy and Price Tag. Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

XTalks

AUGUST 17, 2020

Immunotherapy continues to be a burgeoning field, with immune-based therapies being among the leading treatments being developed in oncology and autoimmunity. There are several different types of immunotherapies, including chemical inhibitors, cell-based therapies (i.e. chimeric receptor antigen [CAR] T cell) immune modulators (i.e.

Protein 98

Protein Engineer Immune Response In-Vivo 98

XTalks

SEPTEMBER 27, 2022

With a list price of $3 million and a recent accelerated US Food and Drug Administration (FDA) approval, bluebird bio’s gene therapy Skysona (elivaldogene autotemcel, eli-cel), has officially become the world’s most expensive drug. Gene Therapy Zynteglo Wins Landmark FDA Approval for Beta Thalassemia. Related: Bluebird’s $2.8M

FDA Approval 52

FDA Approval Gene Therapy Drugs Gene 52

XTalks

JANUARY 19, 2024

Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer. There have been more than $1.7

DNA 66

DNA Radiology FDA Approval Development 66

Pharmaceutical Technology

JANUARY 27, 2023

In an email to Pharmaceutical Technology , he further described the therapy as “the most important advance for treatment of TTP since the documentation of effectiveness of plasma exchange in 1991”. With these therapies, there is the possibility of there being no clinical benefit and an emergence of adverse events.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

XTalks

DECEMBER 21, 2022

The past year has been a strong one for life sciences industries, from pivotal gene therapy approvals to continued innovations in the biotech and medical device spaces. Gene Therapy Approvals. Bluebird bio is a notable mention as it secured FDA approvals for two of its gene therapies, Zynteglo and Skysona.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

Rethinking Clinical Trials

OCTOBER 19, 2022

Due to the low referral rates of fibromyalgia patents to PT (~30%), FM-TIPS had an emergent ethic issue related to patient recruitment and whether the study team could include the American College of Rheumatology criteria to screening to increase eligibility. No single factor is more important than another. pctGR, @Collaboratory1.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

Drug Discovery World

NOVEMBER 9, 2023

These include: Samantha Bailey-Bucktrout, PhD, Senior Vice President, Akamis Bio, on: ‘Tumour specific immunogene therapy to deliver protein therapeutics to solid tumour microenvironments’. Iain Moal, PhD, Scientific Leader, Computational Antibody Engineering, GSK, on: ‘Learning antibody binding affinity using FACS and NGS’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Roots Analysis

AUGUST 28, 2022

Furthermore, several live cell imaging and non-destructive fluorescence histological methods measure limited number of biomarkers at a time and the tags introduced may interfere with the natural function of genes and proteins. For more details on this emerging domain, check out the following report : SPATIAL GENOMICS MARKET.

Genome 52

Genome Genomics RNA Genome Project 52

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research.

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

Drug Discovery World

FEBRUARY 9, 2023

The first is that in-roads made in decoding the complexity of human disease will make drug discovery more difficult and costly, limiting the potential to develop new life-saving therapies. It also carries a much higher price tag for failure. I believe this is where the future of drug research and development hinges.

Drugs 52

Drugs Development Big Data Scientist 52

pharmaphorum

FEBRUARY 26, 2021

Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a strong pharmaceutical backbone that has emerged over the company’s long and varied history. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags.

Sales 126

Sales Production Pharma Companies Marketing 126

The Pharma Data

MAY 4, 2021

The study evaluated the safety and efficacy of two doses of abrocitinib, 100 mg and 200 mg, versus placebo in adults with moderate to severe atopic dermatitis who were on background topical therapy. The study was designed to assess the safety and efficacy of continued treatment with relugolix combination therapy for up to two years.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

MARCH 17, 2023

Furthermore, there has been a shift in the therapy areas that are using risk sharing agreements in the last 10 years. Moreover, many oncology therapies are highly innovative making them a riskier proposition for coverage. In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”.

Marketing 257

Marketing Drugs Research Analyst Manufacturing 257

Pharmaceutical Technology

NOVEMBER 30, 2022

In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. compared to a 5.1%

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. compared to a 5.1%

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246